Acadian Asset Management LLC Caladrius Biosciences, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$1.44 - $2.89 $298,393 - $598,860	-207,218 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$1.39 - $1.87 $70,264 - $94,528	50,550 Added 32.27%	207,218 $296,000
Q3 2020 Nov 09, 2020	BUY	$1.6 - $3.0 $136,233 - $255,438	85,146 Added 119.05%	156,668 $282,000
Q2 2020 Aug 12, 2020	BUY	$1.66 - $2.38 $118,726 - $170,222	71,522 New	71,522 $127,000
Q3 2019 Nov 07, 2019	SELL	$2.22 - $2.99 $36,461 - $49,107	-16,424 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$3.8 - $8.64 $11,096 - $25,228	2,920 Added 21.62%	16,424 $106,000
Q1 2018 Apr 12, 2018	BUY	$3.7 - $6.09 $49,964 - $82,239	13,504 New	13,504 $79,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.